D-1875-2019 Class II Terminated
FDA drug recall D-1875-2019 was initiated by AVKARE Inc. on Aug 28, 2019 and is designated Class II. Reason for recall: Failed Stability Specifications. The recall status is terminated (terminated Oct 27, 2021). Affected quantity: 5953 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 18, 2019
- Initiation Date
- Aug 28, 2019
- Termination Date
- Oct 27, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5953 bottles
Product description
AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.
Reason for recall
Failed Stability Specifications.
Distribution pattern
Nationwide in the U.S.
Code information
Lot #s: 067180011A; 067180012A, Exp. 04/2021; 06718027B1 Exp. 09/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1875-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026